Hyperthermia inhibits transforming growth factor beta-induced Epithelial-Mesenchymal Transition (EMT) in HepG2 hepatocellular carcinoma cells

Hepato-Gastroenterology

Volumn 59, Issue 119, 2012, Pages 2059-2063

  Xu, Xi Ming ^a   Yuan, Guang Jin ^b   Li, Qian Wen ^b   Shan, Shun Lin ^b   Jiang, Shen ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Cancer Center   (China)

Author keywords

Epithelial mesenchymal transition; Hepatocellular carcinoma; Hyperthermia; Transforming growth factor beta

Indexed keywords

EPIDERMAL GROWTH FACTOR; MESSENGER RNA; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER CELL; CELL ADHESION; CELL MIGRATION; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HYPERTHERMIA; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPERATURE; WESTERN BLOTTING;

BLOTTING, WESTERN; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL SHAPE; EPIDERMAL GROWTH FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; HYPERTHERMIA, INDUCED; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

EID: 84872067519     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12404     Document Type: Article

References (25)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
2. Zhu AX: Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be? Oncologist 2006;11:790-800.
3. Falk MH, Issels RD: Hyperthermia in oncology. Int J Hyperthermia 2001; 17:1-18.
4. Wust P, Hildebrandt B, Sreenivasa G, et al.: Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 3:487-497.
5. Horsman MR, Overgaard J: Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol 2007; 19:418-426.
6. Nagashima K, Takagi R, Hoshina H: Effect of local hyperthermia on metastases in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2002; 31:84-89.
7. Voulgari A, Pintzas A: Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 2009; 1796:75-90.
8. Wu Y, Zhou BP: New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai). 2008; 40:643-650.
9. Mani SA, Guo W, Liao MJ, et al.: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133:704-715.
10. Sabbah M, Emami S, Redeuilh G, et al.: Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat 2008; 11:123-151.
11. Theys J, Jutten B, Habets R, et al.: E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiother Oncol 2011; 99:392-397.
12. Okada H, Danoff TM, Kalluri R, Neilson EG: Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 1997; 273:F563-574.
13. Shook D, Keller R: Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development Mech Dev 2003; 120:1351-1383.
14. Yan W, Fu Y, Tian D, et al.: PI3 kinase/Akt signaling mediates epithelial-mesenchymal transition in hypoxic hepatocellular carcinoma cells. Biochem Biophys Res Commun 2009; 382:631-636.
15. Wang Z, Li Y, Sarkar FH: Signaling mechanism(s) of reactive oxygen species in epithelial-mesenchymal transition reminiscent of cancer stem cells in tumor progression. Curr Stem Cell Res Ther 2010; 5:74-80.
16. Witsch E, Sela M, Yarden Y: Roles for growth factors in cancer progression. Physiology (Bethesda) 2010; 25:85-101.
17. Robson EJ, Khaled WT, Abell K, Watson CJ: Epithelial-to-mesenchymal transition confers resistance to apoptosis in three murine mammary epithelial cell lines. Differentiation 2006; 74:254-264.
18. Xu J, Lamouille S, Derynck R: TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009; 19:156-172.
19. Yoneda N, Sato Y, Kitao A, et al.: Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma. Lab Invest 2011; 91:262-272.
20. Tian YC, Chen YC, Chang CT, et al.: Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway. Exp Cell Res 2007; 313:2367-2377.
21. Sawaji Y, Sato T, Takeuchi A, Hirata M, Ito A: Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro. Br J Cancer 2002; 86:1597-1603.
22. Sawaji Y, Sato T, Seiki M, Ito A: Heat shock-mediated transient increase in intracellular 3′,5′-cyclic AMP results in tumor specific suppression of membrane type 1-matrix metalloproteinase production and progelatinase A activation. Clin Exp Metastasis 2000; 18:131-138.
23. Liang X, Zhou H, Liu X, et al.: Effect of local hyperthermia on lymphangiogenic factors VECF-C and -D in a nude mouse xenograft model of tongue squamous cell carcinoma. Oral Oncol 2010; 46:111-115.
24. Nieto MA: The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3:155-166.
25. Peinado H, Portillo F, Cano A: Transcriptional regulation of Cadherins during development and carcinogenesis. Int J Dev Biol 2004; 48:365-375.